These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Serum lipoprotein(a) is increased in hypertensive NIDDM patients. Hancu N; Netea MG; Iancu S Diabetes Care; 1995 Jun; 18(6):879-80. PubMed ID: 7555518 [No Abstract] [Full Text] [Related]
6. The comparison of coronary angiographic profiles between diabetic and nondiabetic patients with coronary artery disease in a Chinese population. Gui MH; Qin GY; Ning G; Hong J; Li XY; Lü AK; Shen WF; Gao X Diabetes Res Clin Pract; 2009 Aug; 85(2):213-9. PubMed ID: 19501926 [TBL] [Abstract][Full Text] [Related]
7. Peripheral atherosclerosis and serum lipoprotein(a) in diabetes. Wollesen F; Dahlén G; Berglund L; Berne C Diabetes Care; 1999 Jan; 22(1):93-8. PubMed ID: 10333909 [TBL] [Abstract][Full Text] [Related]
8. Lipoprotein(a) is an independent risk factor for coronary artery disease in NIDDM patients in South India. Mohan V; Deepa R; Haranath SP; Premalatha G; Rema M; Sastry NG; Enas EA Diabetes Care; 1998 Nov; 21(11):1819-23. PubMed ID: 9802727 [TBL] [Abstract][Full Text] [Related]
9. Lipoprotein (a) interactions with cholesterol-containing lipids on angiographic coronary collateralization in type 2 diabetic patients with chronic total occlusion. Shen Y; Chen S; Dai Y; Wang XQ; Zhang RY; Yang ZK; Hu J; Lu L; Ding FH; Shen WF Cardiovasc Diabetol; 2019 Jun; 18(1):82. PubMed ID: 31234867 [TBL] [Abstract][Full Text] [Related]
10. Relationship between plasma phospholipase A2 concentrations and lipoprotein subfractions in patients with stable coronary artery disease. Xu RX; Zhang Y; Li XL; Li S; Guo YL; Dong Q; Liu G; Li JJ Clin Chim Acta; 2015 Jun; 446():195-200. PubMed ID: 25934512 [TBL] [Abstract][Full Text] [Related]
11. Serum lipids and lipoprotein(a) concentrations in Chinese NIDDM patients. Relation to metabolic control. Chang CJ; Kao JT; Wu TJ; Lu FH; Tai TY Diabetes Care; 1995 Aug; 18(8):1191-4. PubMed ID: 7587858 [TBL] [Abstract][Full Text] [Related]
12. Correlation of lipoprotein (a) to angiographically defined coronary artery disease in Indians. Gupta R; Vasisht S; Bahl VK; Wasir HS Int J Cardiol; 1996 Dec; 57(3):265-70. PubMed ID: 9024915 [TBL] [Abstract][Full Text] [Related]
13. Clinical evaluation of plasma high-density lipoprotein subfractions (HDL2, HDL3) in non-insulin-dependent diabetics with coronary artery disease. Bakogianni MC; Kalofoutis CA; Skenderi KI; Kalofoutis AT J Diabetes Complications; 2001; 15(5):265-9. PubMed ID: 11522502 [TBL] [Abstract][Full Text] [Related]
14. Plasma lipoprotein (a) levels in Turkish NIDDM patients with and without vascular diabetic complications. Erem C; Değer O; Bostan M; Orem A; Sönmez M; Ulusoy S; Telatar M Acta Cardiol; 1999 Aug; 54(4):203-7. PubMed ID: 10511896 [TBL] [Abstract][Full Text] [Related]
15. Lipoprotein (a) and microvascular disease in type 1 (insulin-dependent) diabetes. Winocour PH; Bhatnagar D; Ishola M; Arrol S; Durrington PN Diabet Med; 1991 Dec; 8(10):922-7. PubMed ID: 1838043 [TBL] [Abstract][Full Text] [Related]
16. Regulation of low-density lipoprotein particle size distribution in NIDDM and coronary disease: importance of serum triglycerides. Lahdenperä S; Syvänne M; Kahri J; Taskinen MR Diabetologia; 1996 Apr; 39(4):453-61. PubMed ID: 8777995 [TBL] [Abstract][Full Text] [Related]
17. Association of low plasma high density lipoprotein (HDL)-cholesterol concentration with documented coronary artery disease in males with non-insulin dependent diabetes mellitus. Fuh MM; Shieh SM Horm Metab Res; 1987 Jun; 19(6):267-70. PubMed ID: 3623416 [TBL] [Abstract][Full Text] [Related]
18. Insulin resistance and coronary risk factors in Japanese type 2 diabetic patients with definite coronary artery disease. Matsumoto K; Kizaki Y; Fukae S; Tomihira M; Sera Y; Ueki Y; Tominaga T; Miyake S Diabetes Res Clin Pract; 2001 Mar; 51(3):181-6. PubMed ID: 11269890 [TBL] [Abstract][Full Text] [Related]
19. Relation of angiographically defined coronary artery disease and plasma concentrations of insulin, lipid, and apolipoprotein in normolipidemic subjects with varying degrees of glucose tolerance. Fujiwara R; Kutsumi Y; Hayashi T; Nishio H; Koshino Y; Shimada Y; Nakai T; Miyabo S Am J Cardiol; 1995 Jan; 75(2):122-6. PubMed ID: 7810485 [TBL] [Abstract][Full Text] [Related]
20. Apolipoprotein(a) and cardiovascular disease in type 2 (non-insulin-dependent) diabetic patients with and without diabetic nephropathy. Nielsen FS; Voldsgaard AI; Gall MA; Rossing P; Hommel E; Andersen P; Dyerberg J; Parving HH Diabetologia; 1993 May; 36(5):438-44. PubMed ID: 8314449 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]